QSS
NXTC icon

Quantitative Systematic Strategies’s NextCure NXTC Stock Holding History

Quantitative Systematic Strategies’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,089
Closed -$115K – 714
2020
Q3 		$115K Buy
+1,089
New +$134K 0.02% 563

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Quantitative Systematic Strategies's NXTC Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of NextCure (NXTC) in Q4 2020, closing a stake of 1,089 shares — an estimated $115K sold.

Quantitative Systematic Strategies first reported a position in NXTC in Q3 2020 and held it in 1 quarter. The position peaked at $115K in Q3 2020. 83 funds tracked by Wall St. Rank hold NXTC as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining NextCure position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 1,089 NextCure shares in Q4 2020, an estimated $115K.
  • Quantitative Systematic Strategies first reported a position in NextCure in Q3 2020 and held it in 1 quarter.
  • Quantitative Systematic Strategies's NextCure position peaked at $115K in Q3 2020.
  • 83 funds tracked by Wall St. Rank held NextCure as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.